News & Articles
Selected Filters:
Important considerations for choosing a SARS-CoV-2 assay: Your questions answered
Watch this on-demand webinar to discover the critical factors when choosing an assay for coronavirus testing
SelectScience Cancer Research Summit 2023 taking place November 14
Explore the latest developments in cancer research with fellow scientists, manufacturers, and regulatory experts
Sherlock Biosciences announces clinical data from study of Sherlock CRISPR SARS-CoV-2 Kit
Data shows 100% concordance with results from Dartmouth-Hitchcock’s lab-based polymerase chain reaction (PCR) test method
Agilent receives approval for first PD-L1 companion diagnostic in China
The diagnostic assay can be used to help diagnose patients with non-small cell lung cancer
IDT Signs Strategic Partnership with Chinese Medical Sequencing Firm ChosenMed
Partnership strengthens IDT’s position as an NGS leader in China
Takara Bio USA, Inc. and Integrated DNA Technologies Announce Collaboration to Support Targeted RNA Sequencing
Life science companies combine expertise to enhance transcriptome research
Swift Biosciences and SeraCare Partner on Circulating Tumor DNA Standards for NGS-Based Oncology Assays
Swift Biosciences and SeraCare Partner on Circulating Tumor DNA Standards for NGS-Based Oncology Assays
Horizon Discovery Group plc Introduces Range of Immunohistochemistry HDx Reference Standards
Horizon’s diagnostics division provides consistent and reproducible reference standards for IHC assays
Product Highlight: KASP™ Genotyping Chemistry Applications
Opportunities for Growth at ASCB
Ultra-sensitive NGS-based sequencing targets mosaic disease
Leveraging duplex NGS with automated library prep, researchers move closer to developing liquid biopsy tests for rare genetic disorders